Susquehanna International Group, LLP Reviva Pharmaceuticals Holdings, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 63,169 shares of RVPH stock, worth $80,224. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,169
Previous 41,012
54.03%
Holding current value
$80,224
Previous $52,000
73.08%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RVPH
# of Institutions
40Shares Held
9.97MCall Options Held
133KPut Options Held
43.9K-
Armistice Capital, LLC New York, NY3.19MShares$4.05 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.83MShares$2.33 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.52MShares$1.93 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$1.3 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA685KShares$869,7020.01% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $26M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...